The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17 07:00 ET

Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.

① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.

cls.cnNov 14 20:37 ET

Some Veru Inc. (NASDAQ:VERU) Shareholders Look For Exit As Shares Take 34% Pounding

Simply Wall StNov 14 05:06 ET

Oppenheimer Maintains Veru Inc(VERU.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsNov 5 16:31 ET · Ratings

Veru Announces Meta-analysis Of Body Composition Data From Older Patients With Obesity Which Supports Potential For Enobosarm To Optimize Weight Loss At ObesityWeek

BenzingaNov 5 08:38 ET

Express News | Veru Inc - Topline Results From Phase 2B Quality Trial Expected in January 2025

ReutersNov 5 08:32 ET